All Episodes

E97- Artificial Intelligence in Ophthalmology- Dr. John Kitchens

E96- Tonabersat for DME- DRCR Protocol AN- Dr. Jennifer Sun

E95- Real-World Data of Intraocular Inflammation Associated with Faricimab- Dr. Andrea Montesel

E94 – Systemic Drugs & Underrecognized Maculopathy - Dr. Seong Joon Ahn

E93- Slit-Lamp Detection of PVD: A Simpler Way to Diagnose- Dr. Mohsin Ali

E92-3D Heads-up Display Surgery - Dr. David Chow

E91- Inherited Retinal Disorders- Progress Promise and Lessons— Dr. Ioannis Dimopoulos

E90- DRCR Retina Protocol AO- Home OCT for Management of Wet AMD- Dr. Christina Weng

E89- Artificial Intelligence Image Analysis and Retina Research- Prof. Ursula Schmidt-Erfurth

E88- SIRE sign, Geographic Atrophy trials and treatments- Prof. Robyn Guymer

E87- Pachychoroid Disease Spectrum- A deep Dive- Dr. Angie Fong

E86-8-Year Cognitive Outcomes of Intravitreal Bevacizumab for ROP- Dr. Wei-Chi Wu

E85-EyeNovation Webinar- Double Layer Sign- Dr. Usha Chakravarthy

E84-Long-term Results of PIVOT and Suprachoroidal Viscopexy for RD Repair

E83-Systemic Methotrexate and Lower Rate of PVR Formation- Dr. Cindy Chen

E82-Effect of Perfluorocarbon on Distortion after Repair of Retinal Detachment- Prof. Maher Saleh

E81- Laser Retinopexy in Eyes With High-Risk Lattice Degeneration- Dr. Marc Spirn

E80-Retinal Vasculitis After Intravitreal Pegcetacoplan- Dr. Andre Witkin from ASRS Research and Safety in Therapeutics (ReST) Committee

E79- Interaction Between Optometry and The Specialty of Retina- Panel Discussion

E78- Effect of Scleral Buckle on Outflow Facility, Intraocular Pressure, and Ocular Biomechanics- Dr. Arthur Sit

E77-Indivisual and Systemic Risk Factors for Diabetic Vitrectomy- Dr. Paul Micevych

E76-EDI landscape in Canadian Ophthalmology Residency Programs

E75-PED Height and Variabiility and Outcomes of wet AMD Treatment- Dr. David Sarraf

E74- Full-Thickness Macular Holes in Macular Telangiectasia Type 2- Dr. Jong Park

E73- RD associated with Retinal Dialysis- Dr. Rohowetz

E72-The MERIT Trial

E71- GA progression on Asian vs non-Asian Eyes- Prof Gemmy Cheung

E70-Archway 3 Port Delivery System for wAMD- Dr. Carl Regillo

E69- DRCR Protocol AC Cost Analysis- Dr. William Smiddy

E68-Retinectomy without Lensectomy for RD with PVR- Dr. Jason Hsu

E67-DAVIO Trial- extended release EYP-1901 for wet AMD- Dr. Jay Duker

E66-DIAMONDS Study- Micropulse Laser vs Standard Laser for DME- Prof. Noemi Lois

E65-Incidence of delayed retinal tears after symptomatic PVD- Dr. Jing Chen

E64-DRCR Protocol AC-Aflibercept Monotherapy or Bevacizumab First for DME- Dr. Chirag Jhaveri

E63- Vitrectomy vs Vitrectomy plus Scleral Buckle for Repair of Retina Detachments Due to Giant Retina Tears- Dr. Fernando Arevalo

E62-CRVO and HRVO Associated with COVID-19 Infection in Young Patients-Dr. Avni Finn

E61- Air vs SF6 for small-medium macular holes- Dr. Birger Lindtjørn

E60-Reticular Pseudodrusen and Progression to Advanced AMD- Prof. Robyn Guymer

E59-Novel RCBTB1 variants and late-onset retinal dystrophy- Dr. Brian Ballios

E58-Drainage Techniques for Retina Detachment Repair-Dr. Vinod Kumar

E57-PAMM and the Ischemic Cascade- Dr. David Sarraf

E56-C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy- Dr. Kourous Rezaei

E55-Minimized Eye Movement and Laser for RD Repair- Dr. Gregg Kokame

E54-Macular Hydrodissection, Scleral Needling and Preop Gas- Dr. Efrem Mandelcorn

E53-Optogenetic Vision Recovery for Retinitis Pigmentosa-Drs. Sahel and Roska

E52-Complications of Acute PVD- Dr. Michael Seider

E51-COVID-19 and anti-septics, Ocular Tissue Detection, & Ontario Surgical Backlog-Dr. Tina Felfeli

E50-Vision Recovery Velocity, Momentum and Acceleration-Dr. David Almeida

E49-SCREENROP Study. Refining ROP Screening Guidelines- Dr. Kourosh Sabri

E48-DRCR Protocol W 2-year Results: Prophylactic anti-VEGF for Mod-Severe NPDR

E47-Nondamaging Retinal Laser for Mac Tel Type II- Dr. Daniel Lavinsky

E46- DRCR Protocol AB. Anti-VEGF vs PPV for PDR w Vit Heme-Dr. Andrew Antoszyk

E45- Stress in Medicine- Book Club with Dr. Nina Ahuja

E44- Representation of Women in Vitreoretinal Meetings- Dr. Jay Sridhar

E43- Retinal Findings in Hospitalized COVID-19 Patients- Dr. Leonardo Pereira

E42-Peripheral Exudative Hemorrhagic Chorioretinopathy- Dr. Federico Zicarelli

E41- Treatment of Secondary Macular Holes with Topical Therapy- Dr. John Niffenegger

E40-Retinal Vasculitis and Intraocular Inflammation with Brolucizumab - Dr. Caroline Baumal

E39- Slit Lamp Shields and Face Masks for COVID-19. Dr. Victor Koh

E38-Retinal Biomarkers of Alzheimer's Disease- Drs. Cecilia Lee and Rajendra Apte

E37- Retinal Detachment Rates after Intravitreal Anti-VEGF Injections- Dr. Omesh Gupta

E36- COVID-19 and Preparedness among Ophthalmologists- International Panel Discussion. Drs. Dan Ting, Olivia Li and Steven Yeh

E35- COVID-19 Mortality and Public Mask Usage- Dr. Christopher Leffler

E34- Progression of glaucoma after anti-VEGF injections in susceptible eyes- Dr. Eugene Shildkrot

LEAVO Trial - Comparison of Anti-VEGF drugs for Macular Edema Secondary to CRVO- Dr. Philip Hykin.

E32-Change in Management after Vitreous Culture in Endophthalmitis after Intravitreal Injections-Dr. James Vander

E31- FLUID Study - Dr. Robyn Guymer

E30-Clinical Predictors of Low-Risk Histopathology for Retinoblastoma- Dr. Sameh Soliman

E29-Anti-VEGF Levels in Breast Milk after Intravitreal Injections-Drs. Muni and Juncal

E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel

E27-DRCR Protocol V Results- Anti-VEGF vs Focal Laser vs Observation for DME in Eyes with Very Good Vision- Dr. Jennifer Sun

E26-Autologous Retinal Transplant for Refractory Macular Holes-Dr. Tamer Mahmoud

E25-RIVAL Study: Ranibizumab vs Aflibercept in T&E for wet AMD- Dr. Mark Gillies

E24-Acute Retinal Angiographic Changes with Intravitreal Injections-Dr. Richard Rosen

E23- CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD - Dr. Peter Kertes

E22-Stroke Risk in Patients with CRAO-Dr. Matthew Schrag

E21-Eyes with PDR that were Lost to Followup after PRP or Anti-VEGF Treatment- Dr. Jason Hsu

E20-PIVOT Study: Pneumatic Retinopexy vs PPV for RD Repair

E19-LEAD Trial for Use of Nanopulse Laser for Dry AMD-Prof. Robyn Guymer

E18-Red Blood Cell Distribution and Vision Potential in RVO-Dr. Ahmet Ozkok

E17- 5-year Results of DRCR.net Protocol S: PRP laser vs ranibizumab for PDR- Dr. Jennifer Sun

E16- PLACE Trial: Half-Dose PDT vs Micropulse Laser for Central Serous Chorioretinopathy- Dr. Camiel Boon

E15-Serum VEGF Levels in the IVAN Trial- Dr. Usha Chakravarthy

E14-Plasma VEGF Levels after anti-VEGF Injections (DRCR protocol T)- Dr. Charles Wykoff

E13-Long-term Treatment of Wet AMD by 50+ anti-VEGF Injections-Dr. Sean Adrean

E12-RPE Stem Cells for Dry AMD-Dr. Mark Humayun

E11- Endophthalmitis after Intravitreal Anti-VEGF Injections- Dr. David Almeida

E10-Cytokines Levels and Response to Ranibizumab in DME-Dr. Rajeev Muni

E9-Rate of Macular Atrophy in HARBOR Study- Dr. SriniVas Sadda

E8- DAVE Trial: Targeted Retinal Photocoagulation for DME- Dr. David Brown

E7-Long Term Outcomes of 27-G Vitrectomy- Dr. Ali Khan

E6- YAG Vitreolysis for Symptomatic Floaters- Dr. Chirag Shah

E5-Adding Dexamethasone Implant to Ranibizumab for Persistent DME- Dr. Raj Maturi

E4- 3-year Results of the TREX-AMD Trial- Dr. Charles Wykoff

E3: 5-year Results of Argus II Retina Prosthesis-Dr. Rob Devenyi

Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration

Review of the Clarity Study